Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box P3 (FOXP3) is a transcription factor that serves as the master regulator for the development and suppressive function of regulatory T cells (Tregs) (UniProt P63313). Primarily expressed in CD4+ T cells, FOXP3 is essential for maintaining immune homeostasis and self-tolerance by repressing the production of pro-inflammatory cytokines like IL-2 and upregulating suppressive markers such as CTLA-4 (Fontenot et al., 2003, PMID: 12612552). The FOXP3 locus is regulated by epigenetic modifications, specifically the methylation status of the Treg-specific demethylated region (TSDR), which determines the stability of the Treg lineage (Sakaguchi et al., 2007, PMID: 17200661). Mutations in the FOXP3 gene cause IPEX syndrome, a fatal multi-organ autoimmune disease, highlighting its critical role in preventing autoimmunity (NCBI Gene 50943). In cancer, FOXP3+ Tregs often accumulate in the tumor microenvironment, where they inhibit anti-tumor immunity and correlate with poor clinical outcomes. Therapeutic strategies include using low-dose IL-2 (Aldesleukin) or Sirolimus to expand FOXP3+ Tregs for treating autoimmune diseases and graft-versus-host disease, while research into FOXP3 inhibitors or Treg depletion is ongoing for cancer immunotherapy (Miyara et al., 2014, PMID: 25161031).
Transcriptional regulation of genes involved in regulatory T cell function and stabilization of the Treg phenotype.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box P3 (FOXP3) (FOXP3).